Tablet Coating Defects: Causes and Troubleshooting Guide
Contents
- What a coating defect can tell you
- Common tablet coating defects and first checks
- A step-by-step troubleshooting sequence
- Fictional example
- Common mistakes
- Related reading
- Frequently asked questions
- Does one visual defect always have one root cause?
- Can I use the table to adjust a coating process?
- Are coating defects always a product failure?
- Which records help during an investigation?
- References
In short: Tablet coating defects are visible or performance-related changes in a tablet film. This guide helps production and quality staff identify what to check, while treating each cause as a hypothesis that must be confirmed against the product, equipment, and approved process.
What a coating defect can tell you
A tablet coating process applies a film or other layer to a moving bed of tablets. A defect can begin with the core, coating dispersion, spray pattern, drying conditions, tablet movement, equipment condition, or handling after coating. Similar-looking marks can have different causes, so do not choose a correction from appearance alone.
Start by describing the observation in neutral terms. Note where it appears, how many tablets are affected, whether the pattern is local or spread across the batch, and whether the same feature appears on retained or in-process samples. Compare the observation with the approved product specification and process record before deciding whether it is cosmetic, functional, or a potential quality concern.
The FDA’s current eCFR text for 21 CFR §211.110(a) requires written procedures for appropriate in-process controls and tests or examinations; §211.110(b) says valid in-process specifications must be consistent with the drug product final specifications and derived from previous acceptable process average and process variability estimates where possible. These provisions do not give universal coating settings. FDA’s 1994 inspection guide for oral solid dosage forms also discusses coating-process parameters and possible effects on dissolution. It is an inspection resource, not a recipe for a current product.
Common tablet coating defects and first checks
Use the table to organise an investigation. The entries are possible contributors, not confirmed causes or acceptance criteria.
| Observation | Possible contributors to investigate | Useful first checks |
|---|---|---|
| Orange-peel texture or a dimpled, uneven film | Droplets may not spread evenly before drying; spray pattern, atomisation, dispersion condition, or drying balance may be unsuitable for the process. | Inspect the nozzle and spray pattern, confirm dispersion preparation and agitation, and compare process records with the approved range. |
| Rough, powdery, matte surface | Spray may be drying before droplets form a continuous film; an unstable dispersion or poor spray-to-bed contact may also contribute. | Check for blocked or misaligned nozzles, visible dusting, exhaust conditions, and whether the defect is concentrated near a particular gun or bed area. |
| Picking, sticking, or twinned tablets | Tablets may remain tacky or fail to separate as expected during processing; bed movement, spray coverage, or drying balance may be involved. | Check tablet movement and separation, inspect baffles and pan condition, and compare affected tablets with samples taken at earlier stages. |
| Bridging or filled logos and score lines | Film may build up in recessed areas or the core detail may be shallow; the coating dispersion and spray distribution should be considered. | Inspect the core before coating, compare logo areas across the bed, and check spray coverage and the approved coating composition. |
| Mottling or colour variation | Uneven pigment dispersion, variable film deposition, differences in core colour, or local drying variation may produce a patchy appearance. | Check dispersion mixing, sample several bed locations, inspect uncoated cores, and compare colour observations under consistent lighting. |
| Cracking, peeling, or flaking | Film flexibility, adhesion, coating build, core condition, or handling may be contributing; the exact cause depends on the formulation and process. | Examine where the film separates, check core integrity and coating records, and assess whether damage is already present before unloading. |
| Edge chipping or abrasion | Core strength, bed movement, discharge, transfer, or handling may contribute to visible edge damage. | Compare tablets before and after discharge, inspect transfer points, and check whether the pattern is limited to a specific location or handling step. |
| Uneven gloss or colour shade | Differences in film formation, dispersion condition, drying, lighting, or core appearance can affect visual uniformity. | Compare samples under the same lighting, check dispersion preparation and process records, and separate true colour variation from surface texture. |
Do not change a coating rate, temperature, atomisation setting, or other process parameter because a table lists it as a possible contributor. Use only ranges established for the product and equipment. Example in-house criterion: a site may require the process owner to document the evidence and approve a parameter change before it is trialled; the approval route is set by that company.
A step-by-step troubleshooting sequence
- Describe and contain the observation. Identify the product, batch, process stage, location, and visible pattern. Keep representative samples and avoid discarding affected units before the approved procedure permits it.
- Check the core and materials. Look at uncoated tablets, the coating dispersion, raw-material identity and condition, and the preparation record. Confirm that materials and equipment match the authorised batch instructions.
- Compare process records. Check the documented spray, drying, bed movement, equipment status, interruptions, and operator observations against the product’s approved process. A deviation from a recorded target is evidence to investigate, not proof of a root cause by itself.
- Map the defect. Compare samples from different locations and stages. A repeated pattern near one spray gun, tablet face, or transfer point can help focus the investigation, but it must be supported by records or a controlled examination.
- Test one explanation at a time. Follow the site’s approved investigation and change-control process. Preserve the original observations and document what evidence supports or rules out each explanation. Do not make an unauthorised adjustment to a batch already in process.
- Assess the product impact and disposition. Quality staff should assess the defect against the registered or approved specification, validated process, and relevant test results. Do not assume a defect is acceptable because it looks cosmetic, or reject a batch based only on this general guide.
Fictional example
During coating, an operator notices rough patches on tablets collected near one spray gun. The coating record shows no obvious interruption, and tablets from another bed location look smoother. The operator records the location and time, keeps the samples, and reports the observation through the site procedure. The team then checks the gun, dispersion, spray pattern, and process record before assigning a cause. The example does not establish a required sampling plan or a universal action limit.
Common mistakes
- Treating the symptom as the cause. Orange peel, roughness, and mottling can arise from more than one process or material condition.
- Changing several settings at once. Multiple changes make it difficult to tell which factor affected the result and can create a new problem.
- Using values from another product. Coating ranges depend on formulation, equipment, and product-specific development and validation.
- Ignoring the core. A coating may reveal a core defect or handling damage that started earlier in the process.
- Calling an appearance defect harmless without assessment. Appearance, film integrity, product performance, and approved specifications must be considered together.
Related reading
For equipment-specific steps, see the Neocota and Ganscoater operating SOP. The tablet compression quality attributes guide explains how core properties can affect later processing. For a structured investigation, read handling of incidents and deviations and the process validation guide.
Frequently asked questions
Does one visual defect always have one root cause?
No. The same appearance can have different causes across formulations and equipment. Use the defect as a starting observation, then check batch records, materials, equipment, and samples before concluding.
Can I use the table to adjust a coating process?
No. It lists investigation leads, not operating instructions. Use the approved process ranges and site procedures, and obtain the required authorisation before changing a parameter.
Are coating defects always a product failure?
Not automatically. The significance depends on the product specification, location and extent of the defect, impact on the film or dosage form, and supporting test results. The responsible quality unit determines the appropriate assessment.
Which records help during an investigation?
Useful material may include the batch record, dispersion preparation record, equipment checks, in-process observations, sample descriptions, and results from approved tests. Follow the site’s controlled procedures for recording and handling this information.
References
- U.S. Food and Drug Administration, Guide to Inspections of Oral Solid Dosage Forms Pre/Post Approval Issues for Development and Validation (listed by FDA as “Oral Solid Dosage Forms Pre/Post Approval Issues (1/94)”), January 1994, “Coating Equipment” section. This is an FDA inspection resource, not a product-specific process specification. Official FDA page.
- Electronic Code of Federal Regulations, 21 CFR §211.110, “Sampling and testing of in-process materials and drug products,” current eCFR text accessed 10 November 2026; section last amended in 2008. Official eCFR section.
Related articles
Granulation Endpoint Study Protocol and Data Sheet
Plan a product-specific granulation endpoint study with an ICH Q8(R2) grounded protocol, data sheet, worked example and controls for interpreting results.
Oral Solid Dose Scale-Up Readiness Checklist
Use this oral solid dose scale-up checklist to map product risks, compare equipment and process evidence, and plan readiness reviews before a batch-size change.
Pharma Jobs for Freshers in India: Roles and How to Apply
Pharma jobs for freshers in India: entry roles for D.Pharm, B.Pharm, M.Pharm, B.Sc and ITI candidates, where genuine openings are posted, walk-in tips and safety checks.
Pharma Production Interview Questions for Freshers with Answers
Pharma production interview questions for freshers with model answers on GMP, granulation, compression, coating, line clearance, BMR and yield in OSD plants.